Copper indium selenium nanomaterials for photo-amplified immunotherapy through simultaneously enhancing cytotoxic T lymphocyte recruitment and M1 polarization of macrophages
Source abstract
Abstract
Photoactivated immunotherapy has promising therapeutic efficacy for treating malignancies, especially metastatic tumors. In this study, an erythrocyte membrane-encapsulated copper indium selenium (RCIS) semiconductor nanomaterial was developed to eliminate primary and metastatic tumors, in which copper ions can induce chemodynamic performance, and the narrow band gap endows RCIS with the properties of near-infrared (NIR) light-activated photothermal and photodynamic amplified immunotherapy. Furthermore, RCIS can be used as a nanocarrier to form RNCIS nanoparticles (NPs) by loading NLG919, which blocks the indoleamine 2,3-dioxygenase-1. Under NIR light irradiation, RNCIS NPs release NLG919 at tumor sites via photothermal properties, thereby promoting the recruitment of cytotoxic T lymphocytes and M1 polarization of macrophages, targeting the activation and amplification of immune responses. Herein, in vitro and in vivo studies showed that RNCIS NPs effectively kill cancer cells and eliminate primary and metastatic tumors. Therefore, this study suggests that semiconductor nanomaterials with narrow bandgaps have great potential as photoimmunotherapy agents and NIR light-responsive nanocarriers for controlled release, providing a great paradigm for synergetic tumor photoimmunotherapy. STATEMENT OF SIGNIFICANCE: The Erythrocyte membrane-coated, NLG919-loaded copper indium selenium (RNCIS) semiconductor was designed for eliminating primary and metastatic tumors. RNCIS exhibits chemodynamic, photodynamic, and photothermal activated immunotherapy by inhibiting indoleamine 2,3-dioxygenase-1. This can enhance the recruitment of cytotoxic T lymphocyte and M1 polarization of macrophage, leading to higher synergetic photo-immune therapeutic efficacy.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Cancer, Stress, Anesthesia, and Immune Response
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Adding nanotechnology to the metastasis treatment arsenal10.1016/j.tips.2019.04.002 ↗
2. A malaria vaccine adjuvant based on recombinant antigen binding to liposomes10.1038/s41565-018-0271-3 ↗
3. The immune checkpoint inhibitors: where are we now?10.1038/nrd4476 ↗
4. Immunotherapy with autologous cells
5. In situ modification of the tumor cell surface with immunomodulating nanoparticles for effective suppression of tumor growth in mice10.1002/adma.201902542 ↗
6. Colorectal tumor microenvironment-activated bio-decomposable and metabolizable Cu2O@CaCO3 nanocomposites for synergistic oncotherapy10.1002/adma.202004647 ↗
7. Indoleamine 2,3-dioxygenase and tolerance: where are we now?10.3389/fimmu.2017.01360 ↗
8. A paradigm shift in cancer immunotherapy: from enhancement to normalization10.1016/j.cell.2018.09.035 ↗
9. IDO inhibitors move center stage in immuno-oncology10.1038/nbt0415-321 ↗
10. Targeting tumor-associated macrophages to synergize tumor immunotherapy10.1038/s41392-021-00484-9 ↗
11. The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment
12. Roles of IFN-gamma in tumor progression and regression: a review10.1186/s40364-020-00228-x ↗
13. Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases10.3390/ph7121028 ↗
14. Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy
15. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer10.1016/j.biomaterials.2020.120190 ↗
16. Spatiotemporally synchronous oxygen self-supply and reactive oxygen species production on z-scheme heterostructures for hypoxic tumor therapy10.1002/adma.201908109 ↗
17. Bismuth sulfide nanorods with retractable zinc protoporphyrin molecules for suppressing innate antioxidant defense system and strengthening phototherapeutic effects10.1002/adma.201806808 ↗
18. Inorganic nanomaterials with rapid clearance for biomedical applications10.1039/D0CS00461H ↗
19. Ultrasmall Cu2-xS nanodots as photothermal-enhanced Fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow10.1016/j.biomaterials.2019.03.014 ↗
20. Biodegradable copper-based nanoparticles augmented chemodynamic therapy through deep penetration and suppressing antioxidant activity in tumors10.1002/adhm.202100412 ↗
21. Bimetallic oxide Cu1.5Mn1.5O4 cage-like frame nanospheres with triple enzyme-like activities for bacterial-infected wound therapy
22. A sensitive hydrogen peroxide biosensor using ultra-small CuInS2 nanocrystals as peroxidase mimics10.1016/j.snb.2014.12.052 ↗
23. Tuning the luminescence properties of colloidal I-III-VI semiconductor nanocrystals for optoelectronics and biotechnology applications10.1021/jz301345x ↗
24. Ab initioheat capacity and atomic temperature factors of chalcopyrites10.1103/PhysRevB.75.224301 ↗
25. Deep-level defect enhanced photothermal performance of bismuth sulfide-gold heterojunction nanorods for photothermal therapy of cancer guided by computed tomography imaging10.1002/anie.201710399 ↗
26. Novel bismuth-based nanomaterials used for cancer diagnosis and therapy10.1002/chem.201801588 ↗
27. Nanostructured metal sulfides: classification, modification strategy, and solar-driven CO2 reduction application
28. Synthesis of CuInS2, CuInSe2, and Cu(InxGa1-x)Se2 (CIGS) nanocrystal “Inks” for printable photovoltaics10.1021/ja805845q ↗
29. Selenium nanoparticles for biomedical applications: from development and characterization to therapeutics10.1002/adhm.202100598 ↗
30. Responsive degradable theranostic agents enable controlled selenium delivery to enhance photothermal radiotherapy and reduce side effects10.1002/adhm.202002024 ↗
31. Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy10.1002/adma.201802006 ↗
32. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy10.1002/adma.201701429 ↗
33. Tumor microenvironment-"AND" near-infrared light-activated coordination polymer nanoprodrug for on-demand co-sensitized synergistic cancer therapy10.1002/adhm.202001728 ↗
34. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer10.1039/D1BM01409A ↗
35. Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb10.1007/s002620050296 ↗
36. Photoactivatable immunostimulatory nanomedicine for immunometabolic cancer therapy10.1021/jacs.2c07872 ↗
37. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice10.1136/gutjnl-2019-320105 ↗
38. Ketogenic diet elicits antitumor properties through inducing oxidative stress, inhibiting MMP-9 expression, and rebalancing M1/M2 tumor-associated macrophage phenotype in a mouse model of colon cancer10.1021/acs.jafc.0c04041 ↗
39. Degradable molybdenum oxide nanosheets with rapid clearance and efficient tumor homing capabilities as a therapeutic nanoplatform10.1002/anie.201510597 ↗
40. pH/H2O2 dual-responsive chiral mesoporous silica nanorods coated with a biocompatible active targeting ligand for cancer therapy10.1021/acsami.1c08532 ↗
41. PD-L1 aptamer-functionalized metal-organic framework nanoparticles for robust photo-immunotherapy against cancer with enhanced safety
42. A multifunctional cascade bioreactor based on hollow-structured Cu2 MoS4 for synergetic cancer chemo-dynamic therapy/starvation therapy/phototherapy/immunotherapy with remarkably enhanced efficacy10.1002/adma.201905271 ↗